Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07613710 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Dec 1, 2026 → Feb 9, 2027
See other at-risk trials from H. Lundbeck A/S

Record History

  1. Primary completion pushed from Dec 1, 2026 to Feb 9, 2027 Completion pushed from Dec 18, 2026 to Feb 16, 2027 · Site details revised at 1 of 2 sitesv4 Show 2 more changesShow less
    • Completion pushed from Dec 18, 2026 to Feb 16, 2027
    • Site details revised at 1 of 2 sites
  2. Site details revised at 1 of 2 sitesv3
  3. Eligibility criteria expanded, about 26 wordsv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
H. Lundbeck A/S
20 trials monitored
See 1 trial at risk
The purpose of the trial is to determine if Lu AH69593 is safe and well tolerated. The trial will also look at how the body processes Lu AH69593 with and without food.
Trial Details
NCT Number NCT07613710
Lead Sponsor H. Lundbeck A/S
Conditions Narcolepsy
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov